Predictive Oncology
Predictive Oncology Inc. (NASDAQ: POAI)
is a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.
We dedicate our mission to the millions of healthcare professionals and scientists who take the fight to cancer with every shift. Without their dedication, advancements and cures would be impossible. Likewise, we keep cancer patients and their families in our hearts as we work to eliminate cancer from our lives.
Let us tell you about Predictive Oncology.
Using artificial intelligence, we utilize our collection or 150K+ cancer tumors, categorized by patient type, against drug compounds to determine optimal therapies to be used to eliminate cancer.
Further, the drug discovery community realizes that a genomics-based approach is alone insufficient to achieve the promise of personalized therapeutics. Our multiomic approach stands a much greater chance of success.
Clinical
Testing
Helomics helps to personalize patient therapies
Drug
Discovery
Helomics database of 150K+ tumors aids in reducing discovery timeline
Oncology
Research
TumorGenesis develops living tumors outside the body for study and testing
Drug
Development
Soluble Biotech supplies formulations for delivery of therapeutics and vaccines
Cell
Cultures
zPREDICTA utilizes tumor-specific 3D cell culture models, enabling more successful drug development